Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank31
3Y CAGR-19.1%
5Y CAGR-20.0%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-19.1%/yr
vs +100.7%/yr prior
5Y CAGR
-20.0%/yr
Consistent
Acceleration
-119.8pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$19.13M-28.5%
2023$26.77M+47.8%
2022$18.11M-49.9%
2021$36.12M+152.5%
2020$-68.79M-217.5%
2019$58.55M-17.5%
2018$70.95M+3084.5%
2017$2.23M-97.9%
2016$108.22M-14.7%
2015$126.85M-